Guinea recently experienced its second outbreak of the Ebola virus disease within the last decade. This outbreak began when a case was reported in January 2021 in a town named Gouéké, located over 100 ...

Ebola virus may hide in apparently healthy survivors and trigger new disease outbreaks years later, according to a genomic study published in Nature Wednesday, a finding that challenges scientists’ ...

Johnson and Johnson's two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new articles. Johnson & Johnson's two ...

Scientists and global health officials are investigating whether the current Ebola outbreak in Guinea may have been triggered by a person who was first infected with the virus during the Ebola ...

(HealthDay)—The Ebola outbreak in the Democratic Republic of the Congo (DRC) is over, according to the country's health officials and the World Health Organization. The declaration was made after 42 ...

A patient has tested positive for Ebola in Abidjan, a city of more than 4 million people, marking the first case of the disease in Ivory Coast in more than a quarter century, the World Health ...

A large international research group released a paper today suggesting that Ebola viruses can emerge from five years of dormancy to trigger a new outbreak of infections. While this isn’t the first ...

A health worker waits to handle a new unconfirmed Ebola patient at a newly build MSF (Doctors Without Borders) supported Ebola treatment centre (ETC) on November 7, 2018 in Bunia, Democratic Republic ...

An experimental Ebola vaccine appeared effective in children and adults in a clinical trial. Two doses of Johnson & Johnson's Ebola vaccine appear safe, well tolerated and produce a strong immune ...